Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A

G.S. Pandey, C. Yanover, L.M. Miller-Jenkins, S. Garfield, S.A. Cole, J.E. Curran, Eric Moses, N. Rydz, V. Simhadri, C. Kimchi-Sarfaty, D. Lillicrap, K.R. Viel, T.M. Przytycka, G.F. Pierce, T.E. Howard, Z.E. Sauna, J. Lusher, M. Chitlur, A. Ameri, K. NatarajanR.V. Iyer, A.A. Thompson, R.G. Watts, C.L. Kempton, C. Kessler, J.C. Barrett, E.J. Martin, N. Key, R. Kruse-Jarres, C. Lessinger, K.P. Pratt, N. Josephson, K. Mcredmond, J. Withycombe, C. Walsh, D. Matthews, J. Mahlangu, A. Krause, R. Schwyzer, R. Thejpal, N. Rapiti, Y. Goga, M. Coetzee, D. Stones, K. Mann, S. Butenas, L. Almasy, J. Blangero, M. Carless, R. Raja, E. Reed

Research output: Contribution to journalArticle

47 Citations (Scopus)
Original languageEnglish
Pages (from-to)1318-24
JournalNature Medicine
Volume19
Issue number10
DOIs
Publication statusPublished - 2013

Cite this